| Year |
Citation |
Score |
| 2024 |
Tran J, Alrajhi I, Chang D, Sherwood KR, Keown P, Gill J, Kadatz M, Gill J, Lan JH. Clinical relevance of HLA-DQ eplet mismatch and maintenance immunosuppression with risk of allosensitization after kidney transplant failure. Frontiers in Genetics. 15: 1383220. PMID 38638120 DOI: 10.3389/fgene.2024.1383220 |
0.342 |
|
| 2024 |
Dobrer S, Sherwood KR, Hirji I, Lan J, Gill J, Matic N, Keown PA. Viral load kinetics and the clinical consequences of cytomegalovirus in kidney transplantation. Frontiers in Immunology. 14: 1302627. PMID 38361528 DOI: 10.3389/fimmu.2023.1302627 |
0.338 |
|
| 2023 |
Affdal A, Ballesteros F, Malo MF, Sancho C, Cochran-Mavrikakis SL, Bryan S, Keown P, Sapir-Pichhadze R, Fortin MC. Canadian Kidney Transplant Professionals' Perspectives on Precision Medicine and Molecular Matching in Kidney Allocation. Transplantation Direct. 10: e1565. PMID 38111837 DOI: 10.1097/TXD.0000000000001565 |
0.349 |
|
| 2023 |
Edwards L, Bentley C, Burgess M, Sapir-Pichhadze R, Hartell D, Keown P, Bryan S. Adding epitope compatibility to deceased donor kidney allocation criteria: recommendations from a pan-Canadian online public deliberation. Bmc Nephrology. 24: 165. PMID 37296384 DOI: 10.1186/s12882-023-03224-z |
0.322 |
|
| 2023 |
Slomp C, Edwards L, Burgess M, Sapir-Pichhadze R, Keown P, Bryan S. Public values and guiding principles for implementing epitope compatibility in kidney transplantation allocation criteria: results from a Canadian online public deliberation. Bmc Public Health. 23: 844. PMID 37165330 DOI: 10.1186/s12889-023-15790-w |
0.318 |
|
| 2022 |
Lemieux W, Fleischer D, Yang AY, Niemann M, Oualkacha K, Klement W, Richard L, Polychronakos C, Liwski R, Claas F, Gebel HM, Keown PA, Lewin A, Sapir-Pichhadze R. Dissecting the impact of molecular T-cell HLA mismatches in kidney transplant failure: A retrospective cohort study. Frontiers in Immunology. 13: 1067075. PMID 36505483 DOI: 10.3389/fimmu.2022.1067075 |
0.36 |
|
| 2021 |
Sherwood KR, Nicholl DDM, Fenninger F, Wu V, Wong P, Benedicto V, Cina DP, Wang M, Pobran TD, De Marco ML, Márquez AC, Jassem AN, Sekirov I, Morshed MG, Bardi M, ... ... Keown P, et al. Comprehensive Immune Profiling of a Kidney Transplant Recipient With Peri-Operative SARS-CoV-2 Infection: A Case Report. Frontiers in Immunology. 12: 753558. PMID 34630432 DOI: 10.3389/fimmu.2021.753558 |
0.33 |
|
| 2021 |
Tran JN, Günther OP, Sherwood KR, Fenninger F, Allan LL, Lan J, Sapir-Pichhadze R, Duquesnoy R, Claas F, Marsh SGE, McMaster WR, Keown PA. High-throughput sequencing defines donor and recipient HLA B-cell epitope frequencies for prospective matching in transplantation. Communications Biology. 4: 583. PMID 33990681 DOI: 10.1038/s42003-021-01989-3 |
0.317 |
|
| 2020 |
Cheng AYY, Bajaj HS, Clement M, Sherifali D, Eisen D, Heisel O, Keown P, Richard JF. Assessing the Effect of Quality-Improvement Strategies for Organization of Care in Type 2 Diabetes Outcomes in Adults: Aim-Strait. Canadian Journal of Diabetes. PMID 33223422 DOI: 10.1016/j.jcjd.2020.09.019 |
0.731 |
|
| 2020 |
Oellerich M, Christenson RH, Beck J, Schütz E, Sherwood K, Price CP, Keown PA, Walson PD. Donor-Derived Cell-Free DNA Testing in Solid Organ Transplantation: A Value Proposition. The Journal of Applied Laboratory Medicine. PMID 32447378 DOI: 10.1093/jalm/jfaa062 |
0.302 |
|
| 2020 |
Caulfield T, Murdoch B, Sapir-Pichhadze R, Keown P. Policy Challenges for Organ Allocation in an Era of "Precision Medicine". Canadian Journal of Kidney Health and Disease. 7: 2054358120912655. PMID 32231786 DOI: 10.1177/2054358120912655 |
0.327 |
|
| 2019 |
José Gagliardino J, Arechavaleta R, Goldberg Eliaschewitz F, Iglay K, Brodovicz K, Gonzalez CD, Yu S, Ravi Shankar R, Heisel O, Keown P, Tunceli K. Dyslipidemia: The untreated metabolic dysfunction in people with type 2 diabetes in Latin America. ARETAEUS study outcomes. Journal of Clinical & Translational Endocrinology. 15: 76-80. PMID 30788219 DOI: 10.1016/J.Jcte.2019.01.002 |
0.73 |
|
| 2017 |
Sukma Dewi I, Celik S, Karlsson A, Hollander Z, Lam K, McManus JW, Tebbutt S, Ng R, Keown P, McMaster R, McManus B, Öhman J, Gidlöf O. Exosomal miR-142-3p is increased during cardiac allograft rejection and augments vascular permeability through down-regulation of endothelial RAB11FIP2 expression. Cardiovascular Research. PMID 28073833 DOI: 10.1093/Cvr/Cvw244 |
0.306 |
|
| 2014 |
Shannon CP, Balshaw R, Ng RT, Wilson-McManus JE, Keown P, McMaster R, McManus BM, Landsberg D, Isbel NM, Knoll G, Tebbutt SJ. Two-stage, in silico deconvolution of the lymphocyte compartment of the peripheral whole blood transcriptome in the context of acute kidney allograft rejection. Plos One. 9: e95224. PMID 24733377 DOI: 10.1371/Journal.Pone.0095224 |
0.323 |
|
| 2013 |
Hollander Z, Chen V, Sidhu K, Lin D, Ng RT, Balshaw R, Cohen-Freue GV, Ignaszewski A, Imai C, Kaan A, Tebbutt SJ, Wilson-McManus JE, McMaster RW, Keown PA, McManus BM, et al. Predicting acute cardiac rejection from donor heart and pre-transplant recipient blood gene expression. The Journal of Heart and Lung Transplantation : the Official Publication of the International Society For Heart Transplantation. 32: 259-65. PMID 23265908 DOI: 10.1016/J.Healun.2012.11.008 |
0.314 |
|
| 2011 |
Thompson DM, Meloche M, Ao Z, Paty B, Keown P, Shapiro RJ, Ho S, Worsley D, Fung M, Meneilly G, Begg I, Al Mehthel M, Kondi J, Harris C, Fensom B, et al. Reduced progression of diabetic microvascular complications with islet cell transplantation compared with intensive medical therapy. Transplantation. 91: 373-8. PMID 21258272 DOI: 10.1097/Tp.0B013E31820437F3 |
0.408 |
|
| 2011 |
Gill J, Diec O, Landsberg DN, Rose C, Johnston O, Keown PA, Gill JS. Opportunities to deter transplant tourism exist before referral for transplantation and during the workup and management of transplant candidates. Kidney International. 79: 1026-31. PMID 21228766 DOI: 10.1038/ki.2010.540 |
0.347 |
|
| 2011 |
Kiberd BA, Wrobel M, Dandavino R, Keown P, Gourishankar S. The role of proton pump inhibitors on early mycophenolic acid exposure in kidney transplantation: evidence from the CLEAR study. Therapeutic Drug Monitoring. 33: 120-3. PMID 21192310 DOI: 10.1097/Ftd.0B013E318206A1B1 |
0.36 |
|
| 2011 |
Hollander Z, Chen V, Lin D, Ng RT, Balshaw R, Ignaszewski A, Freue GC, Wilson-McManus J, McMaster RW, Keown P, McManus BM. Predicting Acute Cardiac Allograft Rejection Using Donor and Recipient Gene Expression Journal of Cardiac Failure. 17: S43. DOI: 10.1016/J.Cardfail.2011.06.145 |
0.351 |
|
| 2010 |
Gill JS, Landsberg D, Johnston O, Shapiro RJ, Magil AB, Wu V, Tinckam K, Keown P. Screening for de novo anti-human leukocyte antigen antibodies in nonsensitized kidney transplant recipients does not predict acute rejection. Transplantation. 89: 178-84. PMID 20098280 DOI: 10.1097/Tp.0B013E3181C3503E |
0.367 |
|
| 2010 |
Freue CG, Sasaki M, Wilson-McManus J, Tebbutt S, Borchers C, Smith D, Ng RT, Balshaw R, Keown P, McManus B, McMaster R. A PROTEOMIC BIOMARKER PIPELINE FROM DISCOVERY TO THE CLINIC: VALIDATION IN CARDIAC TRANSPLANTATION Transplantation Journal. 90: 758. DOI: 10.1097/00007890-201007272-01465 |
0.369 |
|
| 2010 |
Lin D, Freue CG, Bergman A, Hollander Z, Sasaki M, Wilson-McManus J, Balshaw R, Ng R, Keown P, McMaster R, McManus B. BIOMARKERS OF CHRONIC HEART ALLOGRAFT REJECTION Transplantation Journal. 90: 303. DOI: 10.1097/00007890-201007272-00572 |
0.303 |
|
| 2010 |
Gunther OP, Ng R, Balshaw R, Lin D, Scherer A, Chen V, Cohen-Freue G, Takhar M, Hollander Z, McMaster R, McManus B, Keown P. CLASSIFICATION OF ACUTE RENAL REJECTION WITH PROTEOGENOMIC ENSEMBLE CLASSIFIERS Transplantation Journal. 90: 245. DOI: 10.1097/00007890-201007272-00463 |
0.344 |
|
| 2010 |
Gunther OP, Chen V, Lin D, Ng R, Balshaw R, Hollander Z, McMaster R, McManus B, Keown P. REFINEMENT OF GENOMIC CLASSIFIERS FOR EARLY ACUTE RENAL ALLOGRAFT REJECTION Transplantation Journal. 90: 244. DOI: 10.1097/00007890-201007272-00462 |
0.356 |
|
| 2010 |
Hollander Z, Lin D, Ng R, Wilson-McManus J, Ignaszewski A, Balshaw R, McMaster R, Keown P, McManus B. 177: Normalization of Heart Failure Genomic Markers after Transplantation The Journal of Heart and Lung Transplantation. 29: S63-S64. DOI: 10.1016/J.Healun.2009.11.187 |
0.342 |
|
| 2009 |
Pescovitz MD, Nezakatgoo N, Lorber MI, Nashan B, Tedesco-Silva H, Kasiske BL, de la Cruz FJ, Russ G, Campistol J, Keown PA. Prospective observational study of sirolimus as primary immunosuppression after renal transplantation. Transplantation. 88: 1010-8. PMID 19855247 DOI: 10.1097/TP.0b013e3181b9d0da |
0.363 |
|
| 2009 |
Dmitrienko S, Balshaw R, Machnicki G, Shapiro RJ, Keown PA. Probabilistic modeling of cytomegalovirus infection under consensus clinical management guidelines. Transplantation. 87: 570-7. PMID 19307796 DOI: 10.1097/Tp.0B013E3181949E09 |
0.744 |
|
| 2009 |
Barraclough KA, Landsberg DN, Shapiro RJ, Gill JS, Li G, Balshaw RF, Chailimpamontree W, Keown PA. A matched cohort pharmacoepidemiological analysis of steroid free immunosuppression in renal transplantation. Transplantation. 87: 672-80. PMID 19295311 DOI: 10.1097/TP.0b013e318195aa54 |
0.347 |
|
| 2009 |
Chailimpamontree W, Dmitrienko S, Li G, Balshaw R, Magil A, Shapiro RJ, Landsberg D, Gill J, Keown PA. Probability, predictors, and prognosis of posttransplantation glomerulonephritis. Journal of the American Society of Nephrology : Jasn. 20: 843-51. PMID 19193778 DOI: 10.1681/Asn.2008050454 |
0.762 |
|
| 2009 |
Cohen Freue G, Lin D, Imai C, Ignaszewski A, Mancini J, Hollander Z, Bergman A, Sasaki M, Wilson-McManus J, Balshaw R, Ng R, Borchers C, Keown P, McManus B, McMaster R. 341: Proteomic Biomarkers of Chronic Heart Allograft Rejection The Journal of Heart and Lung Transplantation. 28: S184. DOI: 10.1016/J.Healun.2008.11.348 |
0.301 |
|
| 2008 |
Warnock GL, Thompson DM, Meloche RM, Shapiro RJ, Ao Z, Keown P, Johnson JD, Verchere CB, Partovi N, Begg IS, Fung M, Kozak SE, Tong SO, Alghofaili KM, Harris C. A multi-year analysis of islet transplantation compared with intensive medical therapy on progression of complications in type 1 diabetes. Transplantation. 86: 1762-6. PMID 19104418 DOI: 10.1097/Tp.0B013E318190B052 |
0.409 |
|
| 2008 |
van Gelder T, Silva HT, de Fijter JW, Budde K, Kuypers D, Tyden G, Lohmus A, Sommerer C, Hartmann A, Le Meur Y, Oellerich M, Holt DW, Tönshoff B, Keown P, Campbell S, et al. Comparing mycophenolate mofetil regimens for de novo renal transplant recipients: the fixed-dose concentration-controlled trial. Transplantation. 86: 1043-51. PMID 18946341 DOI: 10.1097/Tp.0B013E318186F98A |
0.383 |
|
| 2008 |
Thompson DM, Begg IS, Harris C, Ao Z, Fung MA, Meloche RM, Keown P, Meneilly GS, Shapiro RJ, Ho S, Dawson KG, Al Ghofaili K, Al Riyami L, Al Mehthel M, Kozak SE, et al. Reduced progression of diabetic retinopathy after islet cell transplantation compared with intensive medical therapy. Transplantation. 85: 1400-5. PMID 18497678 DOI: 10.1097/Tp.0B013E318172Ca07 |
0.365 |
|
| 2008 |
Keown P, Chailimpamontree W, Dmitrienko S, Li G, Balshaw R, Magil A, Landsberg D, Shapiro RJ, Gill J. GLOMERULONEPHRITIS FOLLOWING RENAL TRANSPLANTATION Transplantation. 86: 43. DOI: 10.1097/01.Tp.0000332665.20822.79 |
0.769 |
|
| 2008 |
Warnock GL, Meloche M, Shapiro J, Ao Z, Keown P, Johnson JD, Verchere B, Partovi N, Thompson D. METABOLIC OUTCOMES AFTER ISLET TRANSPLANTATION Transplantation. 86: 85. DOI: 10.1097/01.Tp.0000332640.70135.2B |
0.377 |
|
| 2008 |
Warnock GL, Meloche M, Shapiro J, Ao Z, Keown P, Johnson JD, Verchere B, Partovi N, Thompson D. RESULTS OF A MULTI-YEAR COMPARISON OF ISLET TRANSPLANTATION WITH INTENSIVE MEDICAL THERAPY ON THE PROGRESSION OF MICROVASCULAR COMPLICATIONS IN TYPE 1 DIABETES Transplantation. 86: 85. DOI: 10.1097/01.Tp.0000332639.32017.24 |
0.381 |
|
| 2008 |
Keown P, Dmitrienko S, Balshaw R, Shapiro RJ, Keown PA. PROBABILISTIC MODELING OF CMV INFECTION IN RENAL TRANSPLANTATION Transplantation. 86: 234. DOI: 10.1097/01.Tp.0000332192.00557.C6 |
0.764 |
|
| 2008 |
Hollander Z, Cohen-Freue G, Lin D, Wilson-McManus J, Balshaw R, Ng R, McMaster R, McManus B, Keown P. DIFFERENTIAL GENE EXPRESSION IN ACUTE AND CHRONIC REJECTION FOLLOWING RENAL TRANSPLANTATION. Transplantation. 86: 735. DOI: 10.1097/01.Tp.0000330599.75790.59 |
0.416 |
|
| 2008 |
Keown P, Hollander Z, Gunther O, Cohen-Freue G, Lin D, Wilson-McManus J, Balshaw R, Ng R, McMaster R, McManus B. LONGITUDINAL PATTERN OF DIFFERENTIAL GENE EXPRESSION WITHIN THE FIRST 3 MONTHS FOLLOWING RENAL TRANSPLANTATION Transplantation. 86: 735. DOI: 10.1097/01.Tp.0000330598.75790.10 |
0.403 |
|
| 2008 |
Hollander Z, Wishart D, Lin D, Peng J, Hau D, Wilson-McManus J, Balshaw R, Ng R, McMaster R, Keown P, McManus B. 418: Metabolomic Biomarkers of Acute Heart Allograft Rejection The Journal of Heart and Lung Transplantation. 27: S211. DOI: 10.1016/J.Healun.2007.11.430 |
0.315 |
|
| 2008 |
Lin D, Hollander Z, Qasimi P, Shen E, Balshaw R, Ng R, McMaster R, Keown P, McManus B, Mui A. 415: Alloreactive T Cell Biomarkers of Acute Heart Allograft Rejection The Journal of Heart and Lung Transplantation. 27: S210. DOI: 10.1016/J.Healun.2007.11.427 |
0.313 |
|
| 2008 |
Cohen Freue G, Bergman A, Hollander Z, Sasaki M, Wilson-McManus J, Balshaw R, Ng R, Keown P, McManus B, McMaster R. 367: Proteomic Biomarkers of Acute Heart Allograft Rejection The Journal of Heart and Lung Transplantation. 27: S193. DOI: 10.1016/J.Healun.2007.11.378 |
0.312 |
|
| 2008 |
Hollander Z, Lin D, Mui A, Wilson-McManus J, Cohen Freue G, Balshaw R, Ng R, McMaster R, Keown P, McManus B. 92: Degree of Concordance between CARGO and Biomarkers in Transplantation The Journal of Heart and Lung Transplantation. 27: S92. DOI: 10.1016/J.Healun.2007.11.097 |
0.369 |
|
| 2007 |
Dmitrienko S, Yu A, Balshaw R, Shapiro RJ, Keown PA. The use of consensus guidelines for management of cytomegalovirus infection in renal transplantation. Kidney International. 72: 1014-22. PMID 17700642 DOI: 10.1038/Sj.Ki.5002464 |
0.738 |
|
| 2007 |
Fung MA, Warnock GL, Ao Z, Keown P, Meloche M, Shapiro RJ, Ho S, Worsley D, Meneilly GS, Al Ghofaili K, Kozak SE, Tong SO, Trinh M, Blackburn L, Kozak RM, et al. The effect of medical therapy and islet cell transplantation on diabetic nephropathy: an interim report. Transplantation. 84: 17-22. PMID 17627232 DOI: 10.1097/01.Tp.0000265502.92321.Ab |
0.44 |
|
| 2006 |
Wen R, Wu V, Dmitrienko S, Yu A, Balshaw R, Keown PA. Biomarkers in transplantation: Prospective, blinded measurement of predictive value for the flow cytometry crossmatch after negative antiglobulin crossmatch in kidney transplantation. Kidney International. 70: 1474-81. PMID 16941026 DOI: 10.1038/Sj.Ki.5001785 |
0.761 |
|
| 2006 |
Büchler M, Chadban S, Cole E, Midtvedt K, Thervet E, Prestele H, Keown P. Evolution of the absorption profile of cyclosporine A in renal transplant recipients: a longitudinal study of the de novo and maintenance phases. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 21: 197-202. PMID 16204301 DOI: 10.1093/Ndt/Gfi113 |
0.418 |
|
| 2006 |
Dmitrienko S, Prasad B, Wu V, Dahlgren T, Yu A, Balshaw R, Keown PA. 22-P Human Immunology. 67: S73. DOI: 10.1016/J.Humimm.2006.08.104 |
0.692 |
|
| 2006 |
Dmitrienko S, Prasad B, Wiltshire A, Dahlgren T, Yu A, Balshaw R, Keown P. 10-P Human Immunology. 67: S114. DOI: 10.1016/J.Humimm.2006.08.092 |
0.703 |
|
| 2005 |
Dmitrienko S, Hoar DI, Balshaw R, Keown PA. Immune response gene polymorphisms in renal transplant recipients. Transplantation. 80: 1773-82. PMID 16378074 DOI: 10.1097/01.Tp.0000184624.54005.9F |
0.739 |
|
| 2005 |
Wilkinson A, Davidson J, Dotta F, Home PD, Keown P, Kiberd B, Jardine A, Levitt N, Marchetti P, Markell M, Naicker S, O'Connell P, Schnitzler M, Standl E, Torregosa JV, et al. Guidelines for the treatment and management of new-onset diabetes after transplantation. Clinical Transplantation. 19: 291-8. PMID 15877787 DOI: 10.1111/J.1399-0012.2005.00359.X |
0.445 |
|
| 2004 |
Johnston A, Belitsky P, Frei U, Horvath J, Hoyer P, Helderman JH, Oellerich M, Pollard S, Riad H, Rigotti P, Keown P, Nashan B. Potential clinical implications of substitution of generic cyclosporine formulations for cyclosporine microemulsion (Neoral) in transplant recipients. European Journal of Clinical Pharmacology. 60: 389-95. PMID 15205865 DOI: 10.1007/S00228-004-0774-8 |
0.458 |
|
| 2004 |
Keown PA. Composite outcomes in renal transplantation using cyclosporine. Transplantation Proceedings. 36: 35S-39S. PMID 15041304 DOI: 10.1016/J.TRANSPROCEED.2004.01.060 |
0.316 |
|
| 2004 |
Heisel O, Heisel R, Balshaw R, Keown P. New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 4: 583-95. PMID 15023151 DOI: 10.1046/J.1600-6143.2003.00372.X |
0.777 |
|
| 2004 |
Whiting JF, Kiberd B, Kalo Z, Keown P, Roels L, Kjerulf M. Cost-effectiveness of organ donation: evaluating investment into donor action and other donor initiatives. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 4: 569-73. PMID 15023149 DOI: 10.1111/J.1600-6143.2004.00373.X |
0.322 |
|
| 2004 |
Balshaw R, Keown P, Budde K, Machnicki G, Kalo Z. FTY720 VS. MYCOPHENOLATE MOFETIL, ECONOMIC IMPACT IN CYCLOSPORINE BASED IMMUNOSUPRESSION FOR DE NOVO RENAL TRANSPLANTATION Transplantation. 78: 511. DOI: 10.1097/00007890-200407271-01378 |
0.448 |
|
| 2004 |
Balshaw R, Machnicki G, Agost Carreño C, Toselli L, Otero A, Keown PA. TWO-HOUR POST-DOSE CYCLOSPORINE LEVELS IN RENAL TRANSPLANTATION IN ARGENTINA: A COST-EFFECTIVE STRATEGY FOR REDUCING ACUTE REJECTION Transplantation. 78: 510-511. DOI: 10.1097/00007890-200407271-01377 |
0.306 |
|
| 2003 |
Pollard S, Nashan B, Johnston A, Hoyer P, Belitsky P, Keown P, Helderman H. A pharmacokinetic and clinical review of the potential clinical impact of using different formulations of cyclosporin A. Berlin, Germany, November 19, 2001. Clinical Therapeutics. 25: 1654-69. PMID 12860490 DOI: 10.1016/S0149-2918(03)80161-3 |
0.424 |
|
| 2002 |
Keown P, Cole E, Muirhead N, Romanet T, Citterio F, Bäckman L, Castillo DD, Balshaw R, Prestele H, Beauregard-Zollinger L, Fornairon S, Murphy G, Perner F, Barama A, Ancona E, et al. Randomized, international study of cyclosporine microemulsion absorption profiling in renal transplantation with basiliximab immunoprophylaxis American Journal of Transplantation. 2: 157-166. PMID 12099518 DOI: 10.1034/J.1600-6143.2002.020207.X |
0.447 |
|
| 2002 |
Keown P, Cole E, Muirhead N, Romanet T, Citterio F, Bäckman L, Castillo DD, Balshaw R, Prestele H, Beauregard-Zollinger L, Fornairon S, Murphy G, Perner F, Wauters JP. Cyclosporine microemulsion (Neoral®) absorption profiling and sparse-sample predictors during the first 3 months after renal transplantation American Journal of Transplantation. 2: 148-156. PMID 12099517 DOI: 10.1034/J.1600-6143.2002.020206.X |
0.425 |
|
| 1999 |
Keown P. Analysis of cost-effectiveness and cost-utility for immunosuppressive protocols in renal transplantation. Transplantation Proceedings. 31: 1140-1. PMID 10083510 DOI: 10.1016/S0041-1345(98)02103-4 |
0.37 |
|
| 1999 |
Gourlay WA, Patterson R, Gill J, Nigro M, Shapiro J, Landsberg DN, Keown P. INFLUENCE OF TRANSPLANT NEPHRECTOMY ON PANEL REACTIVE ANTIBODY TITER AND WAITING TIME FOR SECOND KIDNEY TRANSPLANTS Transplantation. 67: S169. DOI: 10.1097/00007890-199904150-00676 |
0.438 |
|
| 1999 |
Heisel O, Keown P. ANALYSIS OF IL-2 TRANSCRIPTIONAL EVENTS IN ANERGIZED HUMAN T-CELLS Transplantation. 67: S72. DOI: 10.1097/00007890-199904150-00291 |
0.708 |
|
| 1998 |
Keown P, Niese D. Cyclosporine microemulsion increases drug exposure and reduces acute rejection without incremental toxicity in de novo renal transplantation. International Sandimmun Neoral Study Group. Kidney International. 54: 938-44. PMID 9734620 DOI: 10.1046/J.1523-1755.1998.00042.X |
0.384 |
|
| 1998 |
Keown PA, Primmett DR. Cyclosporine: the principal immunosuppressant for renal transplantation. Transplantation Proceedings. 30: 1712-5. PMID 9723252 DOI: 10.1016/S0041-1345(98)00401-1 |
0.358 |
|
| 1998 |
Keown P, Kahan BD, Johnston A, Levy G, Dunn SP, Cittero F, Grino JM, Hoyer PF, Wolf P, Halloran PF. Optimization of cyclosporine therapy with new therapeutic drug monitoring strategies: report from the International Neoral TDM Advisory Consensus Meeting (Vancouver, November 1997). Transplantation Proceedings. 30: 1645-9. PMID 9723226 DOI: 10.1016/S0041-1345(98)00375-3 |
0.436 |
|
| 1998 |
Cole E, Keown P, Landsberg D, Halloran P, Shoker A, Rush D, Jeffrey J, Russell D, Stiller C, Muirhead N, Paul L, Zaltzman J, Loertscher R, Daloze P, Dandavino R, et al. Safety and tolerability of cyclosporine and cyclosporine microemulsion during 18 months of follow-up in stable renal transplant recipients: a report of the Canadian Neoral Renal Study Group. Transplantation. 65: 505-510. PMID 9500624 DOI: 10.1097/00007890-199802270-00009 |
0.413 |
|
| 1997 |
Wrishko RE, Levine M, Primmett DR, Kim S, Partovi N, Lewis S, Landsberg D, Keown PA. Investigation of a possible interaction between ciprofloxacin and cyclosporine in renal transplant patients. Transplantation. 64: 996-9. PMID 9381548 DOI: 10.1097/00007890-199710150-00011 |
0.369 |
|
| 1997 |
Keown PA. Apport du Néoral® en transplantation rénale Biodrugs. 8: 12-14. DOI: 10.2165/00063030-199700081-00007 |
0.314 |
|
| 1996 |
Keown P, Landsberg D, Halloran P, Shoker A, Rush D, Jeffery J, Russell D, Stiller C, Muirhead N, Cole E, Paul L, Zaltzman J, Loertscher R, Daloze P, Dandavino R, et al. A randomized, prospective multicenter pharmacoepidemiologic study of cyclosporine microemulsion in stable renal graft recipients. Report of the Canadian Neoral Renal Transplantation Study Group. Transplantation. 62: 1744-52. PMID 8990355 DOI: 10.1097/00007890-199612270-00009 |
0.429 |
|
| 1996 |
Laupacis A, Keown P, Pus N, Krueger H, Ferguson B, Wong C, Muirhead N. A study of the quality of life and cost-utility of renal transplantation. Kidney International. 50: 235-42. PMID 8807593 DOI: 10.1038/Ki.1996.307 |
0.465 |
|
| 1996 |
Keown P, Häyry P, Morris P, Stiller C, Barker C, Carr L, Landsberg D, Hardie I, Rigby R, Isoniemi H, Gray D, Belitsky P, McDonald A, Mathew T, Clarkson A, et al. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation Transplantation. 61: 1029-1037. DOI: 10.1097/00007890-199604150-00008 |
0.419 |
|
| 1995 |
Gourlay W, Stothers L, McLoughlin MG, Manson AD, Keown P. Transplantation of Pediatric Cadaver Kidneys Into Adult Recipients The Journal of Urology. 153: 322-325. PMID 7815572 DOI: 10.1097/00005392-199502000-00006 |
0.461 |
|
| 1995 |
Sketris I, Yatscoff R, Keown P, Canafax DM, First MR, Holt DW, Schroeder TJ, Wright M. Optimizing the use of cyclosporine in renal transplantation Clinical Biochemistry. 28: 195-211. PMID 7554239 DOI: 10.1016/0009-9120(95)91341-Y |
0.439 |
|
| 1994 |
Jones C, Bleau B, Buskard N, Magil A, Yeung K, Shackleton C, Cameron E, Erb S, Gascoyne R, Keown P. Simultaneous development of diffuse immunoblastic lymphoma in recipients of renal transplants from a single cadaver donor: transmission of Epstein-Barr virus and triggering by OKT3. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 23: 130-4. PMID 8285188 DOI: 10.1016/S0272-6386(12)80823-7 |
0.441 |
|
| 1994 |
Keown PA, Shackleton CR, Ferguson BM. The influence of long-term morbidity on health status and rehabilitation following paediatric organ transplantation. European Journal of Pediatrics. S70-5. PMID 1345109 DOI: 10.1007/BF02125807 |
0.322 |
|
| 1993 |
Solez K, Racusen LC, Marcussen N, Slatnik I, Keown P, Burdick JF, Olsen S. Morphology of ischemic acute renal failure, normal function, and cyclosporine toxicity in cyclosporine-treated renal allograft recipients. Kidney International. 43: 1058-67. PMID 8510383 DOI: 10.1038/Ki.1993.148 |
0.424 |
|
| 1993 |
McCarthy JM, Karim MA, Krueger H, Keown PA. The cost impact of cytomegalovirus disease in renal transplant recipients. Transplantation. 55: 1277-82. PMID 8390731 DOI: 10.1097/00007890-199306000-00013 |
0.327 |
|
| 1993 |
Laupacis A, Pus N, Muirhead N, Wong C, Ferguson B, Keown P. Disease-specific questionnaire for patients with a renal transplant. Nephron. 64: 226-231. PMID 8321355 DOI: 10.1159/000187318 |
0.44 |
|
| 1991 |
McCarthy JM, McLoughlin MG, Shackleton CR, Cameron EC, Yeung CK, Jones EC, Keown PA. Cytomegalovirus epididymitis following renal transplantation. The Journal of Urology. 146: 417-9. PMID 1649926 DOI: 10.1016/S0022-5347(17)37811-4 |
0.316 |
|
| 1990 |
Petric R, Freeman D, Wallace C, Mcdonald J, Stiller C, Keown P. Modulation of experimental cyclosporine nephrotoxicity by inhibition of thromboxane synthesis. Transplantation. 50: 558-563. PMID 2219273 DOI: 10.1097/00007890-199010000-00005 |
0.31 |
|
| 1989 |
Grant D, Zhong R, Gunn H, Duff J, Garcia B, Keown P, Wijsman J, Stiller C. Graft-versus-host disease associated with intestinal transplantation in the rat. Host immune function and general histology. Transplantation. 48: 545-9. PMID 2799906 DOI: 10.1097/00007890-198910000-00001 |
0.31 |
|
| 1989 |
Olsen S, Burdick JF, Keown PA, Wallace AC, Racusen LC, Solez K. Primary acute renal failure ("acute tubular necrosis") in the transplanted kidney: morphology and pathogenesis. Medicine. 68: 173-87. PMID 2654537 DOI: 10.1097/00005792-198905000-00005 |
0.304 |
|
| 1988 |
Petric R, Freeman D, Wallace C, Mcdonald J, Stiller C, Keown P. Effect of cyclosporine on urinary prostanoid excretion, renal blood flow, and glomerulotubular function. Transplantation. 45: 883-889. PMID 3368946 DOI: 10.1097/00007890-198805000-00008 |
0.35 |
|
| 1988 |
Muirhead N, Hollomby DJ, Keown PA. Acute glomerular thrombosis with CsA treatment. Renal Failure. 10: 135-9. PMID 3332724 DOI: 10.3109/08860228709047648 |
0.348 |
|
| 1988 |
Grant D, Duff J, Zhong R, Garcia B, Lipohar C, Keown P, Stiller C. Successful intestinal transplantation in pigs treated with cyclosporine. Transplantation. 45: 279-84. PMID 2964108 DOI: 10.1097/00007890-198802000-00005 |
0.317 |
|
| 1987 |
Grant D, Zhong R, Stiller C, Wallace C, Keown P, Duff J. A comparison of cyclosporine A and Nva2-cyclosporine (cyclosporine G) in a rat renal allograft model. Transplantation. 44: 9-12. PMID 3299927 DOI: 10.1097/00007890-198707000-00003 |
0.311 |
|
| 1986 |
Keown PA, Stiller CR. Kidney transplantation Surgical Clinics of North America. 66: 517-539. PMID 3520894 DOI: 10.1016/s0039-6109(16)43938-1 |
0.358 |
|
| 1982 |
Rankin RN, Keown PA, Ulan RA, Stiller CR. Percutaneous transluminal dilatation of transplant renal artery stenosis. Postgraduate Medical Journal. 57: 300-3. PMID 6458031 DOI: 10.1136/pgmj.57.667.300 |
0.31 |
|
| 1981 |
Keown PA, Stiller CR, Ulan RA, Sinclair NR, Wall WJ, Carruthers G, Howson W. Immunological and pharmacological monitoring in the clinical use of cyclosporin A. Lancet (London, England). 1: 686-9. PMID 6110913 DOI: 10.1016/S0140-6736(81)91971-1 |
0.322 |
|
| Show low-probability matches. |